Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease

E-ISSN： 1875-533x|23|7|686-700

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.7, 2016-02, pp. : 686-700

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson’s Disease

Current Pharmaceutical Design, Vol. 22, Iss. 10, 2016-03 ,pp. : 1305-1311

Bentham Science Publishers

Access to resources Recommend Favorite

Ropinirole in the treatment of Parkinson’s disease

By Zesiewicz T.A. Hauser R.A.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 697-710

Informa Healthcare

Access to resources Recommend Favorite

Glutamate Receptors and Parkinsons Disease: Opportunities for Intervention

By Marino M.J. Valenti O. Conn P.J.

Drugs & Aging, Vol. 20, Iss. 5, 2003-01 ,pp. : 377-397

Adis International

Access to resources Recommend Favorite

Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4936-4947

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Human Astrocytes' Calcium-sensing Receptors for Treatment of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4990-5000

Bentham Science Publishers

Access to resources Recommend Favorite